Previous studies in mice have reported five different microRNAs (miRNAs; miR-219-1/132/183/96/182) to be modulators of the endogenous circadian clock and have presented experimental evidence for some of the genes involved in the molecular clock machinery as target sites. Moreover, disruption of circadian rhythms has long been implicated in the pathophysiology of major depression (MD). We investigated these miRNAs and some of their target sites at the sequence and functional levels as possible predisposing factors for susceptibility to MD and related chronobiological subphenotypes. Mutational screening was performed in a sample of 359 MD patients and 341 control individuals. We found a significant association between the T allele of the rs76481776 polymorphism in the pre-miR-182 and late insomnia in MD patients. Previous studies have reported an association between insomnia and CLOCK gene, a predicted miR-182 target site. A significant overexpression of miR-182 was detected by quantitative real-time polymerase chain reaction in cells transfected with the mutated form of the pre-miR-182 when compared with wild-type form. Moreover, a significant reduction in luciferase activity of plasmids with 3 ′ UTR of ADCY6, CLOCK and DSIP genes was shown when transfecting cells with the mutated form of pre-miR-182 compared with cells that did not express miR-182. These data indicate that abnormal processing of pre-miR-182 in patients carrying the T allele of the rs76481776 polymorphism may contribute to the dysregulation of circadian rhythms in MD patients with insomnia, which could influence expression levels of the mature form of miR-182 and might increase downregulation in some of its target genes.
INTRODUCTION
Circadian rhythms are 24 h biological oscillations, which, in mammals, are controlled by a master clock located in the suprachiasmatic nuclei (SCN) of the hypothalamus. The master clock, in turn, synchronizes circadian oscillators in peripheral tissues and adjusts the rhythmic fluctuation of a broad range of cellular and physiological functions such as body temperature, hormone release, metabolic rate or the sleep/ wake cycle (1) . These circadian rhythms of hundreds of clockcontrolled genes allow organisms to anticipate daily changes in the environment, and appear to depend on transcriptional -translational feedback loops of activating and repressing elements that produce oscillations in gene activation (2) .
MicroRNAs (miRNAs) are small, non-coding, regulatory transcripts of 22 nucleotides in length that influence trans- * To whom correspondence should be addressed at: Center for Genomic Regulation (CRG), PRBB Building, Room 521, Charles Darwin s/n (Dr Aiguader 88), Barcelona 08003, Catalonia, Spain. Tel: +34 933160177; Fax: +34 933160099; Email: monica.gratacos@crg.cat lation and stability of mRNAs, thus contributing to the regulation of gene expression affecting a variety of biological processes (3) . Owing to their ability to modulate expression at the transcriptional and posttranscriptional level (mechanisms known to be involved in the regulation of circadian oscillation) miRNAs have been suggested as potential players in the SCN clock (4) . The first evidence of miRNA cycling in mammals came from the recent identification of two brainspecific miRNAs (miR-132 and miR-219-1) reported to be modulators of endogenous circadian clock in the SCN in mice (5) . Those authors showed that miR-132 plays a role in the photic entrainment of circadian rhythms, the process by which the SCN is synchronized to a 24 h period by the daily light -dark cycle. miR-219-1 modulates period length, which naturally occurs as a light -dark cycle of 24 h. Moreover, the authors functionally characterized miR-132 and miR-219-1 within the context of the circadian clock and presented experimental evidence of genes Rfx4 and Phlpp as respective targets (5) . In another study, several miRNAs specifically expressed in the mouse retina exhibited daily oscillations in their transcription levels (6) . Among this subgroup of miRNAs were members of the miR-183/96/182 cluster, with predicted targets known to be important in the regulation of the circadian rhythm such as Adcy6 or Clock. The authors validated Adcy6 as a target site for miR-182 and miR-96, and they also showed that the expression of these miRNAs was in antiphase to the Adcy6 transcript (6) .
Dysfunction of circadian rhythms is hypothesized to play a role in the pathophysiology, disease recurrence and the circadian phenotypes typically observed in major depression (MD; reviewed in 7). A high proportion of MD patients, for example, present abnormal timing of sleep and wakefulness, appetite and social rhythms or daily mood fluctuations. Interestingly, these manifestations of abnormal circadian function return to normality with antidepressant or mood stabilizer treatment and patient recovery (8) . Following this hypothesis, several authors have explored the possible link between variants in genes pertaining to the molecular clock and the susceptibility to develop major mood disorders (MMD), including unipolar and bipolar patients, finding strong evidence of this relationship in different studies (9 -14) . As well as disease susceptibility, circadian phenotypes have also been investigated in MMD patients. CLOCK is associated with early, middle and late insomnia, diurnal activity pattern and insomnia evolution during antidepressant treatment (15) (16) (17) , and PER3 is associated with worse mood in the evening, diurnal preference and delayed sleep phase syndrome (9, 14, 18) .
We therefore hypothesized that naturally occurring variations in the sequences of miR-132, miR-219-1 or the miR-183/96/182 cluster (or in their precursor forms), which act as modulators of the endogenous clocks, or changes in their target binding sites in the RFX4, PHLPP, ADCY6 and CLOCK genes known to be involved in circadian clock period and entrainment could be related to a higher susceptibility to MD and, more specifically, to related chronobiological subphenotypes frequently observed among these patients. We tested this possibility by targeted resequencing of the genomic regions containing these miRNAs and the abovementioned corresponding target sites in a sample of 359 unrelated subjects with MD and 341 control individuals, and then performed association analyses comparing the distribution of the genetic variation in relation to MD diagnosis and circadian rhythm-related subphenotypes.
RESULTS

Resequencing of pre-miRs and targets sites in genes involved in circadian rhythm
First, using sequence alignments, we confirmed that the five different pre-miRNAs (miR-132, miR-219-1 and the miR-183/96/182 cluster) and their mature forms are conserved between mice and humans (Supplementary Material, Fig. S1A ). Furthermore, we verified that RFX4 and PHLPP (target sites of miR-132 and miR-219-1, respectively), and CLOCK and ADCY6 (target sites for the miR-183/96/182 cluster) are also conserved predicted targets in humans (Supplementary Material, Fig. S1B ).
Afterwards, we performed a targeted mutational screening in a sample of 359 MD patients looking for sequence variations in the genomic regions containing the precursor forms of the cited miRNAs and also in the corresponding target sites of the above-mentioned genes. Demographics and clinical characteristics of the sample are provided in Table 1 .
We did not find sequence changes in the mature or the precursor forms of miR-132, miR-219-1 and miR-183 in the MD samples. Nor did we find changes with respect to their predicted targets, RFX4 and PHLPP (respective targets for miR-132 and miR-219-1), and ADCY6 and CLOCK (targets for the cluster of miR-183/96/182). Nevertheless, we found four sequence variants within the precursor form of miR-182 (rs76481776, already described, and rs77586312, rs75953509 and rs80041074, newly discovered) and two changes in the pre-miR-96 (rs41274239 and rs73159662, already described) (Supplementary Material, Fig. S2 ). Regarding pre-miR-182, each of the two new variants rs77586312 and rs75953509 were present in only one out of 359 MD patients and in none of the controls, whereas rs76481776 and rs80041074 were encountered in both patients and control individuals. Regarding variations in pre-miR-96, rs73159662 was present in both groups studied, whereas rs41274239 was found only in MD patients ( Table 2 ). All sequence variants found in the different amplicons studied, although not in our regions of interest, are summarized in Supplementary Material, Table S1 .
Association analyses of rs76481776 in pre-mir-182
Only the rs76481776 polymorphism was tested in association analyses, as it was the only variant being a common SNP at both groups studied [minor allele frequency (MAF checked the expression levels of miR-182 and miR-182 * (the less predominantly expressed mature form originating from the passenger strand of the precursor) in cells transfected with a plasmid encoding for the wild-type pre-miR-182 (p182_wt) or one carrying the change that we identified (p182_MUT). We found that, in comparison with cells transfected with p182_wt, cells transfected with p182_MUT overexpressed the mature form of miR-182 [fold change (FC) ¼ 1.29; P ¼ 0.04; Fig. 1A ], but not the mature form of miR-182 * (Fig. 1B) . Fold changes and P-values for all comparisons performed are shown in Supplementary Material, Table S3 .
Target prediction of hsa-miR-182
In order to test whether the newly discovered variant has a role in the regulation of circadian rhythmicity, we first performed an in silico analysis looking for potential targets of miR-182 that take part in the regulation of the clock machinery. We found 16 predicted target genes involved in molecular clock regulation, the most interesting ones for the present study being ADCY6, CLOCK and DSIP (Supplementary Material, Table S4 ). We selected ADCY6 gene as a positive control, since it is a validated target of miR-182 in mice and is known to be involved in circadian rhythm regulation (6) . We also selected CLOCK gene because it is an important molecular clock regulator which has been previously associated with insomnia in unipolar and bipolar MD patients (15) . Finally, we also selected the delta sleep-inducing peptide (DSIP) because it is known to affect the sleep-wakefulness cycle (19) .
Functional analysis of miR-182 targeting by luciferase assays
To test whether the presence of the variant rs76481776 in the sequence of the pre-miR-182 could affect the regulation of the above target genes, we compared the effects of the regulation produced by p182_wt and by p182_MUT by means of luciferase assays. Regarding ADCY6, as expected, we observed a trend towards a decreased luciferase activity in cells transfected with p182_wt [difference (diff) ¼ 0.80; P ¼ 0.056; Fig. 2A ], and also a significant and more intense reduction when cells were transfected with p182_MUT (diff ¼ 0.66; P ¼ 0.0005; Fig. 2A ). The same pattern was observed when studying 3 ′ UTR of the CLOCK gene: we detected a reduction of the luciferase activity when transfecting cells with p182_wt (diff ¼ 0.79; P ¼ 0.048; Fig. 2B ) and a more pronounced reduction in cells transfected with p182_MUT (diff ¼ 0.64; P ¼ 0.0004; Fig. 2B ). Finally, for DSIP gene, a significant decrease in the luciferase activity was seen only in cells transfected with the p182_MUT compared with p182_NULL (diff ¼ 0.72; P ¼ 0.0056; Fig. 2C ). Differences and P-values for all comparisons performed are shown in Supplementary Material, Table S5 .
DISCUSSION
The aim of the present study was to explore whether genetic variants in five miRNAs and in some of their target genes, all related to the regulation of circadian rhythmicity (5, 6) , are involved in the pathophysiology of MD and in the circadian phenotypes typically observed in these patients. To our * expression levels between HeLa cells transfected with p182_wt (encoding for normal precursor form of miR-182) or p182_MUT (encoding for pre-miR-182 carrying the variant rs76481776) were performed for different experimental situations (transfecting only p182_wt or p182_MUT or cotransfecting them with pFirefly and pRenilla vectors to check for possible cotransfection effects). The expression values of miR-182 and miR-182 * were normalized to that of RNU58B (used as an endogenous control) and the results in different cases were then referred to the expression levels of non-transfected HeLa cells treated with Lipofectamine 2000. Cotransfection of p182_wt or p182_MUT with pFirefly and pRenilla produced no effect on the overexpressed levels of mature form miR-182 in cells transfected with p182_MUT.
* Statistically significant P-values for differences in FCs (P , 0.05).
knowledge, this is the first attempt to evaluate whether variations in miRNAs are potential regulators of the molecular clockwork in MD patients.
In our study we found that the common variant rs76481776, located in the precursor form of miR-182, is significantly associated with late insomnia in MD patients. In addition, we provide functional evidence for a role of this variant in mature form processing. Pre-miR-182 carrying rs76481776 overexpresses the mature form of miR-182 compared with the wild-type precursor form and, in concordance with these results, it causes a significant reduction in luciferase activity when testing the 3 ′ UTR of ADCY6, CLOCK and DSIP genes, all of them encoding proteins that are possibly involved in sleep/wake cycle regulation. This is in agreement with previous studies which showed that SNPs or mutations affecting not only the miRNAs but also their precursor forms, as well as the miRNA-binding sites, could potentially be associated with different human diseases such as cancers, hypertension, asthma or other neuropsychiatric disorders (reviewed in 20, 21) .
The most widely accepted model of sleep regulation involves the interaction of a homeostatic process and a circadian timing process which, although generated independently, mediates the propensity, length, incidence of episodes and intensity of sleep (22) . It is known that clock genes have a crucial role in sleep homeostasis processes (reviewed in 23), and it has been widely demonstrated that sleep, sleep deprivation and wakefulness not only alter brain gene expression (24 -27) , but also change the expression of 50 miRNAs, which can be either up or downregulated depending on the brain area examined (28) . Thus, it would be no surprise if molecular changes not only in particular miRNAs but also in their mRNA clock targets could regulate sleep homeostasis. This hypothesis is best exemplified by our results on the CLOCK gene. First, we found a significant association of miR-182 and late insomnia in MD patients. Second, this miRNA has CLOCK as a target effector. Finally, there is evidence in animals and humans that molecular changes in CLOCK influence sleep-related traits (reviewed in 29). Clock mutation in mice, for example, acts not only on sleep architecture but also on the amount of sleep without affecting sleep intensity, the most striking effect being that mutant mice spend less time asleep (30) .
In healthy human adults, a polymorphism in the CLOCK gene (3111T/C; rs1801260) has been associated with evening preference and delayed timing of the sleep-wake cycle (31, 32) . In relation to circadian rhythm sleep disorders, in a patient with non-24 h sleep -wake disorder, the expression profile of clock genes, CLOCK among them, was normalized after successful treatment resulting in synchronization of his sleep -wake cycle to a 24 h day (33) . Moreover, the 3111T/C SNP mentioned above has been associated with early, middle and late insomnia, diurnal activity pattern and insomnia evolution during antidepressant treatment in bipolar disorder patients (15) (16) (17) . This particular variant was not associated with any of the phenotypes studied in our sample (data not shown), including the three types of insomnia considered. The methodological strategies used in the original report (15) and in our study are the same (HAM-D-21), and the genotype frequencies in both populations for this single nucleotide polymorphism (SNP) are very similar (data not shown). Thus, the most probable explanation for the inconsistency of the results between the two studies is a type II error due to a smaller sample size in our case, which could have led to a false-negative result. Alternatively, another untyped potential functional variant in linkage disequilibrium with the rs1801260 SNP could be the true causal variant of the phenotype effects. In this situation, population differences in the linkage disequilibrium of the region could account for the lack of association of the rs1801260 SNP and insomnia in our sample. Apart from this SNP, two other rare changes in the 3 ′ UTR of CLOCK gene have been found in two MD patients with sleep disturbances but not in healthy subjects (34) . One of these changes (rs70965446) was indeed found in two of our MD patients, both of whom presented severe late insomnia. None of the above SNPs in the 3 ′ UTR of CLOCK is located in the predicted target site of miR-182, and none of them has been shown to alter the CLOCK Figure 2 . In vitro functional effects of variant rs76481776 in the pre-miR-182 on reporter gene expression measured by luciferase-reporter assays. pFirefly constructs containing 3 ′ UTR of ADCY6 (pADCY6) (A), CLOCK (pCLOCK) (B) or DSIP (pDSIP) (C) genes were cotransfected to HeLa cells with pRenilla (as a control of transfection efficiency) and with p182_wt (encoding for normal precursor form of miR-182), p182_MUT (encoding for pre-miR-182 carrying rs76481776) or p182_NULL (expressing no mature form of miR-182 and used as an unspecific effect control). Luciferase activities were measured 24 h after transfection and firefly luciferase activity was normalized to Renilla luciferase activity. Box plots represent the distribution of ratios of firefly/Renilla luciferase activities in each experiment condition (bold line: median; bottom and top line of the box: first and third quartile, respectively). FLuc/RLuc (ratio of firefly luciferase activity/Renilla luciferase activity).
* Statistically significant P-values for differences in FLuc/RLuc ratio (P , 0.05).
transcriptional activity but, in view of our results, which implicate miR-182 in its regulation, it is tempting to speculate that they could influence the accessibility of the miRNA-RISC complex or the coordination of miRNA with other regulatory elements, as has been previously suggested for SNPs near an miRNA target site (21) . Besides posttranscriptional regulation of circadian rhythms by miRNAs, other mechanisms are possibly contributing to control expression of core components circadian clock genes. Disruption of circadian rhythms is believed to play a critical role in cancer development and, indeed, there are different examples of alternative methylation patterns in clock genes in these pathologies, such as hypermethylation of PER3 in patients with chronic myeloid leukemia (35) , transcriptionally silencing of BMAL1 gene by means of hypermethylation in hematologic malignancies (36) , and hypermethylation in the CLOCK promoter reducing the risk of breast cancer (37) . Moreover, there is recent evidence that epigenetic mechanisms such as DNA methylation might also contribute to the developmental expression of clock genes (38) . Other regulation steps in the control of circadian clock account for posttranslational modifications of clock proteins by phosphorylation, ubiquitination and acetylation (39) . Thus, for a complete knowledge and understanding of clock genes regulation, it is important to focus not only in the study of transcription factors and modulators of the mammalian circadian clock, but also to take into account other mechanisms, such as posttranscriptional regulation by miRNAs (widely discussed in this work), posttranslational mechanisms and epigenetic factors.
There are some limitations in the present study that must be acknowledged. First, the sample size limits the statistical power of the study since most changes found are rare alleles with very low frequencies (MAF ranging from 0.1 to 1, Table 2 ), which made it impossible to perform association analyses except for the common variant rs76481776. In this case, the statistical power to detect a reliable association with the rs76481776 polymorphism (presenting an MAF of 7.1) is 80%. Nonetheless, it is noticeable that three out of these five rare changes found in the pre-miR-96 and pre-miR-182 were present only in MD patients and in none of the control individuals screened, which supports the emerging hypothesis of rare alleles underlying complex disorders (40) . Second, it is not possible to rule out an association between the rs76481776 SNP and late insomnia regardless of the presence of an MD. In our study, information about insomnia was not available for controls, since insomnia variables were obtained through the items 4, 5 and 6 of the HAM-D-21 which evaluate the presence and severity of the insomnia subtypes as symptoms of depression in individuals undergoing a major depressive episode. Consequently, further studies between this variant and insomnia in general population should be performed. Third, all the functional experiments performed were in vitro and, consequently, we suggest that further evidence is required from experiments carried out on other in vivo systems in order to better understand the potential role of the variant rs76481776 and miR-182 itself in sleep regulation. Finally, these potentially exciting results must be considered as preliminary until further confirmation is obtained in independent samples. In summary, in view of the functional consequences of the rs76481776 described here, and considering the association of this SNP with late insomnia in MD patients demonstrated in this study, we suggest a precise posttranscriptional regulation of circadian rhythms by miRNAs, and specifically by miR-182, in which the rs76481776 SNP in its precursor form could play an important role in fine-tuning its target sites involved in the control of sleep and wakefulness.
MATERIALS AND METHODS
Subjects and clinical assessment
We studied a clinical sample of 359 unrelated patients and 341 control individuals. Patients with a major depressive episode of at least moderate severity were consecutively recruited from the Psychiatry Department at the 'Hospital Universitari de Bell- The control group consisted of 341 unrelated blood donors recruited from the Blood and Tissue Bank from the Catalan Health Service, who were matched to cases for ethnicity.
All subjects provided written informed consent through the local Institutional Review Board-approved procedures prior to participation. The study complied with the guidelines of the Medical Ethical Committee from each of the participating institutions.
Identification of miRNAs and their targets in humans
MiRNAs of interest (miR-132, miR-219-1 and miR-183/96/182 cluster) were first explored for their conservation between species through the comparison of their respective sequences available from the public miRBase database (46) from The Wellcome Trust Sanger Institute (http://microrna.sanger.ac.uk/ sequences). We then checked the conservation in humans of the RFX4, PHLPP, CLOCK and ADCY6 gene target sites in mice, using the web-based versions of TargetScan (http://genes.mit. edu/tscan/targetscanS2005.html), PicTar (http://pictar.bio.nyu. edu) and MiRanda (http://microrna.sanger.ac.uk/targets; http:// www.microrna.org). We also used these programs to screen for predicted target genes for hsa-miR-182.
Mutational screening
The reference sequences of the miRNAs and their target sites were obtained from human genome assembly hg18 available at the public repository of the University of Santa Cruz, California (UCSC, http://genome.ucsc.edu/), March 2006 freeze (NCBI Build 36.1). PCR primers for each genomic DNA fragment were designed by Primer3 (http://frodo.wi.mit.edu/ cgi-bin/primer3/primer3_www.cgi) and were also used as primers for forward and reverse direct sequencing (Supplementary Material, Table S6 ). PCR products were confirmed by 1.5% agarose gel electrophoresis and were then enzymatically purified using ExoSAP-IT (USB Corporation, Cleveland, OH, USA). The purified PCR products were sequenced using the BigDye Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) and sequence purification was performed with Millipore Montage seq96 (Millipore Corporation, Billerica, MA, USA). Sequencing was performed using an ABI Prism w 3730xl DNA Analyzer (Applied Biosystems). We used the software SeqScape (version 2.5, Applied Biosystems) to assist in mutation detection, and we visually verified each mutation. We first tested all the MD samples for the different regions and, when sequence variants were found, we analyzed the control samples for that specific region.
Statistical analysis of polymorphisms
Power calculations used Quanto software v.1.2.3 (47, 48) . Polymorphisms with an MAF of .0.5 were tested in controls to ensure the fitting with Hardy -Weinberg equilibrium. Case -control association analyses to test for diagnosis phenotype (total MD sample and stratified analysis considering unipolar and bipolar depressives) and association analyses of the insomnia (early, middle or late), defined by a score of 1 or 2 on items 4, 5 and 6, respectively, in the HAM-D-21 in MD patients were performed by logistic regression, whereas linear regression was used for quantitative traits (scores in SPAQ and MEQ). All analyses testing diagnosis phenotype were adjusted for the covariate sex, and when interrogating circadian rhythm-related phenotypes (namely insomnia subtypes, seasonality and diurnal preference scores) all the association analyses were adjusted for the following covariates: sex, age at collection and polarity. Four different genetic models were considered in these analyses: codominant, dominant, recessive and additive. Finally, P-values were computed using the likelihood ratio test and the best model was selected based on the Akaike information criteria (49) . All analyses were performed using the SNPassoc R package (50). As we performed eight different variable association analyses, a P-value of ,0.00625 was considered statistically significant after Bonferroni correction for multiple testing.
Plasmids construction
We used an expression vector that encodes the precursor form of miR-182 under an EF-1a promoter, which ensures a high level of expression in mammalian cells (miRNASelect TM pEP-miR-182 Expression Vector; Cell Biolabs, Inc.). From pEP-miR-182 (p182_wt), we generated two constructs: one lacking a region of the insert and not expressing pre-miR-182 (p182_NULL), and another one, which was generated through site-directed mutagenesis, carrying the C/T change (rs76481776) in the pre-miR-182 sequence (p182_MUT). First, to generate p182_NULL, we performed a sequential double-digestion of the p182_wt vector with BamHI and NheI restriction enzymes (New England Biolabs, Inc.) and a posterior filling-in of 5 ′ overhangs to form blunt ends with DNA Polymerase I, Large (Klenow) Fragment (New England Biolabs, Inc.). Second, to obtain p182_MUT construct, single nucleotide substitution (C.T) corresponding to rs76481776 was introduced into the DNA sequence of p182_wt with the use of a QuikChange Multi Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) according to the manufacturer's instructions and using the following primers: 5 ′ -CGAGGACTCAG CCAGCACCCTGTGCAC-3 ′ (forward) and 5 ′ -GTGCACAG GGTGCTGGCTGAGTCCTCG-3 ′ (reverse). For the luciferase assays, we generated three different firefly luciferase pGL4.13 constructs (pFirefly). DNA fragments corresponding to 929, 704 and 936 bp of the 3 ′ UTR regions with predicted target sites for miR-182 of ADCY6, CLOCK and DSIP genes, respectively, were amplified by PCR with PfuTurbo w DNA polymerase (Stratagene) from control individuals' DNA samples containing no variation in the sequences. The primers used for each of the genes were the following, all of them containing an XbaI restriction site (New England Biolabs, Inc.) at the 5 ′ end: ADCY6 (forward: 5 ′ -AC ACACTCTAGAATGCTTGCCTTTGCAATACC-3 ′ ; reverse:
The PCR fragments obtained were purified, XbaI digested and cloned into an XbaI site located downstream of the firefly luciferase-reporter gene in the pGL4.13 vector (Promega Corporation, Madison, WI, USA). Finally, the pFirefly constructs obtained (pADCY6, pCLOCK and pDSIP) were propagated in E. coli One Shot w TOP 10 cells (Invitrogen). For all constructs, the authenticity, the orientation of the inserts and the presence of the mutations were confirmed by direct sequencing.
Real-time quantitative reverse transcription PCR
HeLa cells were maintained in Dulbecco's Modified Eagle's Medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml Streptomycin (GIBCO TM , Invitrogen). HeLa cells were seeded at 6.75 × 10 4 cells/well in 24-well plate and transfected 24 h later using Lipofectamine 2000 (Invitrogen) with the pEP-miR-182 constructs described above (1 mg of p182_wt, p182_MUT or p182_NULL) and with the pFirefly (50 ng) and the pRenilla (15 ng of pGL4.75) if required. Total RNA, including miRNA, was isolated using miRNeasy Mini Kit (Qiagen, Hilden, Germany) according to manufacturer's instructions 24 h after transfection (when optimal miR-182 and miR-182 * expression was found). Ten nanograms of total RNA were used for reverse transcription as measured by a ND-1000 spectrophotometer (Nanodrop, Wilmington, DE, USA). cDNA was made using the TaqMan w MicroRNA Reverse Trancription Kit (Applied Biosystems) and the specific reverse transcription primers for hsa-mir-182, hsa-mir-182 * and the housekeeping gene RNU58B (Applied Biosystems). The corresponding PCR primers were used with TaqMan w Universal PCR Master Mix, No AmpErase w UNG (Applied Biosystems) using ABI PRISM 7900HT Fast PCR systems (Applied Biosystems). Control reactions containing no reverse transcriptase and no cDNA template were also performed. Crossing-point values, the point at which the fluorescence of a sample rises above the background fluorescence, were obtained for each reaction in the different experimental conditions performed and were used for relative quantification analyses. Three different transfections with their subsequent RNA extraction were performed for each experimental condition. Two different reverse transcription assays with follow-up qRT-PCR were made from each isolated RNA, and each experimental condition was measured in triplicate. Finally, some verifications were done before performing the final experiments in order to corroborate the overexpression of miR-182 and miR-182 * in cells transfected with p182_wt compared with non-transfected cells, and also that p182_NULL plasmid used in further experiments expressed none of the mature forms of the miRNA.
Luciferase activity assays
HeLa cells were maintained in Dulbecco's Modified Eagle's Medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml Streptomycin (GIBCO TM , Invitrogen). HeLa cells were seeded at 1.35 × 10 4 cells/well in 96-well plates and cotransfected 24 h later using Lipofectamine 2000 (Invitrogen) with the appropriate pEP-miR-182 constructs (200 ng of p182_wt, p182_NULL or p182_MUT), the pRenilla (3 ng) and the Firefly reporter constructs described above (24 ng of pADCY6, pCLOCK or pDSIP) or the empty pFirefly vector (10 ng). Activities of Firefly and Renilla luciferases were determined 24 h after transfection using the Dual-Glo TM Luciferase Assay System (Promega) according to the manufacturer's instructions. Relative reporter activity was obtained by normalization to Renilla luciferase activity (ratio Firefly luciferase/Renilla luciferase). Each experimental condition was measured in triplicate for each luciferase assay, and each luciferase assay was performed four times.
Data and statistical analyses of functional assays
For the qRT-PCR assays, FCs were calculated to compare expression values of both miR-182 and miR-182 * normalized to that of RNU58B among different experimental conditions. These FCs were obtained from a linear mixed effects model (51) that accounted for different sources of variations; three different transfections and two reverse transcriptions per transfection (see Supplementary Material, Methods for details). For the luciferase assays, FCs were also calculated to compare the relative reporter activity among the different experimental conditions via a linear mixed effects model, which also accounted for experimental day variability (see Supplementary Material, Methods for details).
